from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1562c/treZ

LFCtreatmentdescriptionclass of inhibitor

0.337

Amikacinug/mL Amikacintranslation

0.363

Cap5-10ug/mL Capreomycintranslation

0.648

Rox10-50 ug/mL Roxithromycintranslation

-0.430

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.664

Rif0.2-5ug/mL Rifampicintranscription

0.191

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.078

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.131

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.498

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.029

Clofazimine10-13 ug/mL Clofaziminerespiration

0.232

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.353

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.529

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.614

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.672

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.189

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.132

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.907

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.494

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.406

Nigericin50 uM Nigericinrespiration

-0.270

TRC10-150 ug/mL Triclosanrespiration

-0.168

TRZ10-25 ug/mL Thioridazinerespiration

-0.775

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.374

menadione6-10 ug/mL Menadionerespiration

-0.724

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.271

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.179

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.427

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.925

NRP_1Non-replicating persistence stage 1dosRassociated

0.267

Amp0.2mg/mL AmpicillincellWall

-0.664

Cephalexin20-100 ug/mL CephalexincellWall

1.645

Cerulenin0.32-5 ug/mL CerulenincellWall

1.614

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.676

EMB10-20 ug/mL EthambutolcellWall

-0.094

Eta12-40 ug/mL EthionamidecellWall

0.032

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.759

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.213

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.827

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.368

BZA0.12 mg/mL BenzamidearomaticAmides

0.164

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.517

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.292

H2O24 mM hydrogen peroxideDNAdamaging

-0.015

Levo10 ug/mL LevofloxacinDNAdamaging

0.286

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.575

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.670

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.139

UVUV-irradiationDNAdamaging

-0.884

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.912

Antimycin12.5-50 ug/mL Antimycin A?

-0.316

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.672

PA_110-50 ug/mL Antitubercular compound PA-1?

0.752

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.146

PA8240.2-2 ug/mL PA-824?

-0.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.287

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.868

Verapamil50 uM Verapamil?

-0.322

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.322

methoxatin10-20 ug/mL Methoxatin?